LCLingling Cheng

Lingling Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lingling Cheng has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Gaojie Song

    Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China

    3 shared publications
  • Jianjun Xiong

    Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China

    1 shared publication
  • Xingnuan Li

    Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang 332005, China

    1 shared publication

Latest Publications

  • Open Access

    Mitochondria–Lysosome Quality Flux in Aging Mesenchymal Stem/Stromal Cells: Quality-Control Bottlenecks and Therapeutic Opportunities for Regenerative Decline

    by Lingling Cheng, Gaojie Song

    Aging mesenchymal stem/stromal cells (MSCs) lose regenerative capacity as redox imbalance, mitochondrial damage, defective organelle quality control and chronic inflammation converge. Yet these processes are commonly considered in isolation, obscuring whether damaged mitochondrial cargo reaches lysosomes and is ultimately degraded. Here, we define mitochondria–lysosome quality flux (MLQF) as an author-proposed, evidence-graded framework that tracks mitochondrial damage from recognition and sorting through lysosomal delivery to terminal lysosomal degradation in aging MSCs. The framework explicitly separates delivery to an acidic compartment from completed degradation and distinguishes direct MSC evidence from cross-model mechanisms and candidate pathways. MSC studies most strongly support macroautophagy-dependent mitophagy, particularly when assessed using dynamic flux reporters. By contrast, mitochondria-derived vesicles and microautophagy-like or piecemeal routes remain incompletely validated in MSCs. Studies in non-MSC systems further show that mitochondria–lysosome contact sites can support lysosomal acidification, although their contribution to natural MSC aging remains unresolved. By locating rate-limiting defects across this continuum, MLQF provides a testable basis for linking incomplete mitochondrial clearance to inflammatory signaling, lineage drift and regenerative decline, and for selecting bottleneck-matched interventions.


  • Open Access

    Ferroptosis in bovine mastitis: multidimensional mechanisms, stratified assessment, and intervention prospects

    by Lingling Cheng, Gaojie Song

    Mastitis remains a major constraint on dairy cow health and production efficiency. Even after pathogen clearance, inflammation, epithelial injury, and lactation impairment can persist, indicating that disease outcome is not determined solely by pathogen burden. Ferroptosis, a regulated form of cell death driven by iron-dependent membrane phospholipid peroxidation, provides a mechanistic framework that links iron dyshomeostasis, oxidative injury, and irreversible tissue damage. Current evidence suggests that increased oxidative load, altered iron flux, restriction of the cysteine–glutathione (GSH)–glutathione peroxidase 4 (GPX4) axis, and remodeling of the membrane-lipid substrate pool can jointly lower the ferroptotic threshold of mammary epithelial cells in the mastitic microenvironment. Within defined pathogen contexts and temporal windows, oxidized lipids and damage-associated molecular patterns (DAMPs) may further contribute to inflammatory amplification, blood–milk barrier disruption, and lactation decline. However, direct in vivo causal evidence in bovine mastitis remains limited. Ferroptosis further intersects with pyroptosis, necroptosis, and other regulated cell-death pathways, underscoring its strong context dependence. This review synthesizes current evidence on the core mechanisms of ferroptosis, its triggers in the mastitic microenvironment, the translation of molecular injury into tissue dysfunction, evidence standards for causal attribution, boundaries of contribution, and prospects for stratified assessment and intervention. In sum, ferroptosis is best regarded as a candidate framework for host-damage amplification in mastitis rather than a universally established execution pathway. Advancing its translational value will require spatiotemporally resolved evidence, cell-type specificity, and causal rescue experiments.


  • Open Access

    The DNA Methylation–Autophagy Axis: A Driver of MSC Fate Imbalance in Skeletal Aging and Osteoporosis

    by Gaojie Song, Xingnuan Li, Jianjun Xiong, Lingling Cheng

    Age-related osteoporosis is driven in part by senescence-associated rewiring of bone marrow mesenchymal stem cells (MSCs) from osteogenic toward adipogenic fates. Accumulating evidence indicates that epigenetic drift and reduced autophagy are not isolated lesions but are mechanistically coupled through a bidirectional DNA methylation and autophagy axis. Here, we summarize how promoter hypermethylation of genes involved in autophagy and osteogenesis suppresses autophagic flux and osteoblast lineage transcriptional programs. Conversely, autophagy insufficiency reshapes the methylome by limiting methyl donor availability, most notably S-adenosylmethionine (SAM), and by reducing the turnover of key epigenetic regulators, including DNA methyltransferases (DNMTs), ten-eleven translocation (TET) dioxygenases, and histone deacetylases (HDACs). This self-reinforcing circuitry exacerbates mitochondrial dysfunction, oxidative stress, and inflammation driven by the senescence-associated secretory phenotype (SASP), thereby stabilizing adipogenic bias and progressively impairing marrow niche homeostasis and bone remodeling. We further discuss therapeutic strategies to restore balance within this axis, including selective modulation of epigenetic enzymes; activation of AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (mTOR) signaling with downstream engagement of Unc-51-like autophagy-activating kinase 1 (ULK1) and transcription factor EB (TFEB); targeting sirtuin pathways; mitochondria- and autophagy-supportive natural compounds; and bone-targeted delivery approaches or rational combination regimens.